Drostanolone Propionate 100 AMPULES - Genetic Pharmaceuticals

Drostanolone propionate made its pharmaceutical debut as a DHT-based steroid, specifically designed for treating estrogen-sensitive breast cancer in postmenopausal women. Developed by Syntex and distributed as Drolban by Eli Lilly, the compound saw widespread clinical use during the 1970s and 1980s. Its key advantage was its lack of aromatization, allowing anti-estrogenic benefits with fewer side effects than testosterone. Though withdrawn from medical markets in the 1990s, drostanolone gained popularity among athletes for its role in producing a dry, defined appearance during cutting phases.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Drostanolone Propionate 100 AMPULES by Genetic Pharmaceuticals, consult with your doctor or healthcare professional.